Brief: Valeo Pharma Provides Update On Ophthalmology Business Unit
04/07/2023 12:38
July 4 (Reuters) - Valeo Pharma Inc VPH.TO :
* VALEO PHARMA PROVIDES UPDATE ON OPHTHALMOLOGY BUSINESS
UNIT
* VALEO PHARMA:NOTES FROM RELEASE ISSUED BY NOVARTIS ON
JUNE30
THAT NOVARTIS AGREED TO SELL XIIDRA FOR TREATMENT OF SIGNS,
SYMPTOMS OF DRY EYE DISEASE
Source text for Eikon: ID:nCNWrFh7Da
Further company coverage: VPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada